Transforming Cannabis Today.
Leading Psychedelics Tomorrow.
Headland aims to become the Caribbean’s leading
plant-based medicinal wellness company
— from cultivation to clinics.
Headland operates two wholly-owned subsidiaries.
Windican Health has a government-issued license and 100 dedicated acres to cultivate, manufacture, and export cannabis and related products in St. Vincent and the Grenadines. Our company is committed to setting the standard of pharmaceutical-grade, safe and pure medicinal cannabis products in the West Indies and beyond.
SVG Biomed is dedicated to unlocking the healing power of psychedelics. The company has some of the most comprehensive psychedelic licenses in the industry, including psilocybin, ibogaine, MDMA and other entheogens. SVG Biomed is poised to develop clinical and pharmaceutical-grade plant-derived products for physician-directed medical care. We will have the first state-of-the-art medical clinic designed exclusively for psychiatric treatment and research.
Headland provides access to plant-based medicines for a wide range of conditions.
Depression
ADHD
Anxiety
Addiction
Pain
Eating disorders
PTSD
End-of-life distress
Leadership
Cy Campbell
CEO, Headland Chair,
Windican Health
Dr. Dawn DeCunha
Psychedelics Policy and Applications, SVG Biomed
Robin Alistair Lewis
Execuitve Vice President &
Co-founder, Headland
Dr. Carolina Landolt-Marticorena
Medical and Research Advisory Board Chair, Windican Health
Caribbean Home, Global Impact
Based in St Vincent and the Grenadines, Headland West Indies (Headland) is life sciences and biotechnology platform built to ethically harness the healing power of psychedelics, fungi, and medicinal plants. We develop medicines deemed effective in improving mental health, limiting substance abuse, and treating brain injury.
Headland’s licenses enable its scientists to leverage the most comprehensive portfolio of plant-based protocols available globally in the company’s quest to become a Caribbean leader in plant-based medicinal wellness - from cultivation to clinics.
The Platform is focused on 4 specific areas:
Research & Development: Headland’s R&D efforts are dedicated to conducting clinical trials and creating I.P. from research centred around Phytochemical discovery and Mycology
Natural Health & Wellness Products: Headland will refine entheogens and other medicinal plants to manufacture a portfolio of natural health products and plant-derived pharmaceuticals for individuals seeking both medicinal or pharmaceutical remedies and general wellness.
Therapeutic Treatment and Clinics: Headland's therapeutic practice partners with high-pedigree clinical brands to provide best-in-class therapeutic offerings to aid patients experiencing trauma, depression, PTSD, and addiction.
“Headland West Indies is founded on a deep reverence for the importance of traditional plant-based medicines. We pay tribute to the Indigenous cultures and communities that have preserved and nurtured them over time. Our scientists look forward to deploying modern biotechnologies that further empower those remedies to heal patients in novel and effective ways.”
– Cyril Campbell, CEO
Latest News
